Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001085695 | SCV000285243 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000230792 | SCV000729661 | likely benign | not provided | 2020-11-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000230792 | SCV001150692 | likely benign | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001011360 | SCV001171669 | likely benign | Hereditary cancer-predisposing syndrome | 2019-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV001085695 | SCV002041335 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001011360 | SCV002532784 | benign | Hereditary cancer-predisposing syndrome | 2021-03-29 | criteria provided, single submitter | curation | |
Prevention |
RCV003897525 | SCV004712068 | likely benign | TSC2-related condition | 2023-01-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |